Cardiovascular Trial Sponsorship Significantly Impacts Findings
Favorable outcomes seven times more likely in industry- versus NIH-sponsored trials
Addition of Immunosuppression No Benefit in IgA Nephropathy
No improvement in outcomes, more adverse effects for intensive supportive care + immunosuppression
Lixisenatide Doesn’t Affect Cardiovascular Risk in T2DM
Findings among patients with type 2 diabetes and recent acute coronary syndrome
Vitamin D3, Placebo Both Improve Chronic Low Back Pain
No significant between-group difference in decrease in mean pain VAS score, mean change in chronic pain
Evidence Doesn’t Support Monthly Labs With Isotretinoin
Significant changes in values of several laboratory tests, but changes don't meet high-risk criteria
AMA: Case Before Supreme Court Threatens Patient Privacy
Case involves Medical Board obtaining three years of prescribing history for doctor, after single complaint
Anthracyclines More Neurotoxic Than Other Breast CA Regimens
More negative effects on specific cognitive domains, network connections for breast cancer survivors
Safety Concerns Linked to Herbal Medicine Use in Cancer
Concerns include altered pharmacodynamics, direct toxic effects, increased chemosensitivity
Metformin Does Not Boost Glycemic Control in T1DM
Small, but temporary, beneficial effect from metformin was seen early on
November 2015 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for November 2015. This roundup includes the latest...
